<DOC>
	<DOCNO>NCT02169973</DOCNO>
	<brief_summary>The purpose study measure uptake , distribution , clearance 11C-MK-3168 Positron Emission Tomography ( PET ) scan model tissue specific kinetics 11C-MK-3168 appropriate input function human brain Part A ; measure block retention 11C-MK-3168 estimated time maximum plasma concentration dosing ( tmax ) follow single oral dos JNJ-42165279 model exposure/enzyme interaction JNJ-42165279 Part B ; measure saturation enzyme inhibition brain steady state plasma concentration JNJ-42165279 ( Day 8 ) 7 once-daily dos JNJ-42165279 conduct PET study 11C-MK-3168 trough plasma concentration Day 2 Part C .</brief_summary>
	<brief_title>A Study Investigate Regional Brain Kinetics Positron Emission Tomography Ligand 11C-MK-3168 Blocking Retention Ligand Human Brain JNJ-42165279</brief_title>
	<detailed_description>This open-label ( [ participant investigator ] know treatment participant receive ) study . This study consist 3 consecutive part : A , B , C. Each part consist screen phase ( 21 2 day prior study medication ) , treatment phase ( Part A : 1 day ; Part B : 8 day ; Part C : 8 day ) , end-of-study/ follow-up visit ( within 5 7 day last PET scan ) . In treatment phase Part A , participant undergo baseline PET/computed tomography scan ( administration 11C-MK-3168 Day 1 ) ; In Part B , participant undergo baseline PET scan , follow 2 post-treatment PET scan 2 single dos JNJ-42165279 Days 1 8 ; Part C , participant undergo baseline PET scan , follow 2 post-treatment PET scan 24 hour postdose JNJ-42165279 Days 1 7 . Safety evaluate assessment adverse event , vital sign , 12-lead electrocardiogram , clinical laboratory testing , physical examination ( include weight tympanic temperature [ temperature measure ear ] ) , neurological examination . The total duration study participation participant approximately 4 week Part A approximately 5 week Parts B C .</detailed_description>
	<criteria>Body mass index ( BMI ) 18 30 kg/m2 inclusive ( BMI = weight/height2 ) Nonsmoker ( smoke 3 month prior screen ) Agree use one protocol mention barrier method birth control Exposed 1 millisievert ionizing radiation year start study Clinically significant abnormal laboratory value abnormal physical neurological examination screen Any clinically significant Magnetic Resonance Imaging ( MRI ) abnormalities screen , determined neuroradiologist , relevant study Allen test ( test ass arterial blood flow hand ) indicating abnormal blood supply hand Has implant embed metal object , fragment head body would present risk MRI scanning procedure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>11C-MK-3168</keyword>
	<keyword>JNJ-42165279</keyword>
	<keyword>Human Brain</keyword>
</DOC>